 |
(NaturalNews) The FDA is reconsidering its approach to COVID-19 vaccine approvals for the upcoming season, citing insufficient data on booster effectiveness… |
FDA reconsiders COVID-19 booster approvals, with Makary emphasizing the need for “good data”
ByPimpHesus
May 4, 2025